People who inject drugs in Asia are disproportionately affected by HIV, despite the region seeing an overall decline in HIV rates. In 2018, UNAIDS reported HIV prevalence among people who inject drugs in Southeast Asia to be highest in the Philippines (29%), Indonesia (28.76%), and Thailand (19.02%). Access to combination prevention services, especially Harm Reduction, remains a challenge in a few countries according to survey data from 2016–2018.
The Global Fund’s Harm Reduction Advocacy in Asia grant (HRAsia) is based on learning from the earlier national programme. Since 2017, the regional grant focuses on advocacy to achieve the long-term sustainability of harm reduction interventions in line with the 90-90-90 targets in seven high priority countries of Asia through our country partners in Cambodia, India, Indonesia, Nepal, Philippines, Thailand and Vietnam. Our technical partners under the regional grant are the International Drug Policy Consortium, a global network of 182 NGOs, Asian Network of People who Use Drugs, the regional community-led organization and Harm Reduction International, a leading NGO dedicated to reducing the negative health, social and legal impacts of drug use and drug policy.
At the regional level:
A not-for-profit Section 8 Company with Registration No: U85310DL1999NPL098570
©2021 All Rights Reserved by Alliance India